Consistent Safety Profile with up to 4 Years of Apremilast Treatment: Analysis of Data from 1,493 Subjects with Psoriatic Arthritis in 3 Large, Phase III, Long-Term Studies

Conference contribution


Publication Details

Author(s): Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, Paris M, Teng L, Wollenhaupt J
Publication year: 2017
Volume: 69
ISSN: 2326-5191
eISSN: 2326-5205


FAU Authors / FAU Editors

Schett, Georg Prof. Dr. med.
Lehrstuhl für Innere Medizin III


External institutions with authors

Celgene Corporation
Complejo Hospitalario Universitario de Santiago de Compostela
Monash University
Schön Klinik Hamburg Eilbek
Swedish Medical Center
University of California, San Diego
University of Orléans / Université d'Orléans
University of Toronto


How to cite

APA:
Mease, P.J., Gladman, D.D., Gomez-Reino, J.J., Hall, S., Kavanaugh, A., Lespessailles, E.,... Wollenhaupt, J. (2017). Consistent Safety Profile with up to 4 Years of Apremilast Treatment: Analysis of Data from 1,493 Subjects with Psoriatic Arthritis in 3 Large, Phase III, Long-Term Studies.

MLA:
Mease, Philip J., et al. "Consistent Safety Profile with up to 4 Years of Apremilast Treatment: Analysis of Data from 1,493 Subjects with Psoriatic Arthritis in 3 Large, Phase III, Long-Term Studies." 2017.

BibTeX: 

Last updated on 2018-03-12 at 09:08